Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aimei Health Technology CoAFJK 16 Equity-to-Asset is 0.66 as of Mar. 2026, which is 31% below its 10-year median of 0.95. GuruFocus rates AFJK with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 541 Diversified Financial Services companies, Aimei Health Technology Co ranks worse than 68.02% on this metric.
Aimei Health Technology Co (NAS:AFJK) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Aimei Health Technology Co Equity-to-Asset Related Terms
Aimei Health Technology Co Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFJK vs BRRN, RDAC, MSSAF: Equity-to-Asset Comparison
For the Shell Companies subindustry, Aimei Health Technology Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aimei Health Technology Co Equity-to-Asset vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Aimei Health Technology Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Aimei Health Technology Co's Equity-to-Asset falls into.
Aimei Health Technology Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Aimei Health Technology Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aimei Health Technology Co (AFJK) has a Equity-to-Asset of 0.66 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aimei Health Technology Co and its competitors. This is 31% below median its historical median of 0.95. Over the past decade, Aimei Health Technology Co's Equity-to-Asset has ranged from 0.09 to 0.99. According to the industry distribution chart, Aimei Health Technology Co ranks #368 out of 541 companies in the Diversified Financial Services industry, placing it in the top 68%.
Is Aimei Health Technology Co's Equity-to-Asset too high?
Aimei Health Technology Co's current Equity-to-Asset of 0.66 is 31% below median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.99. The Diversified Financial Services industry median Equity-to-Asset is 0.90. Aimei Health Technology Co's value of 0.66 is 26.7% below this industry median. Based on the distribution chart, Aimei Health Technology Co ranks #368 out of 541 companies in the Diversified Financial Services industry, which is below the industry midpoint. Overall, Aimei Health Technology Co has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Aimei Health Technology Co's Equity-to-Asset compare to BRRN and RDAC?
According to the Diversified Financial Services industry distribution chart, Aimei Health Technology Co ranks #368 out of 541 companies for Equity-to-Asset. This places Aimei Health Technology Co in the lower half of its industry. The industry median Equity-to-Asset is 0.90. Aimei Health Technology Co's value of 0.66 is 26.7% below this benchmark. Historically, Aimei Health Technology Co's own Equity-to-Asset has ranged from 0.09 to 0.99 over the past decade. While the company's 10-year median is 0.95 vs. the industry median of 0.90, Aimei Health Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Diversified Financial Services company?
The median Equity-to-Asset among Diversified Financial Services companies is 0.90, based on 541 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aimei Health Technology Co's current Equity-to-Asset of 0.66 is 26.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Aimei Health Technology Co and its competitors. For the Diversified Financial Services industry, the median Equity-to-Asset is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aimei Health Technology Co's current Equity-to-Asset is 0.66, which is 31% below median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimei Health Technology Co stock overvalued right now?
Aimei Health Technology Co (AFJK) has a current Equity-to-Asset of 0.66. The current Equity-to-Asset is 0.66, which is 31% below median its 10-year median of 0.95 and 26.7% below the Diversified Financial Services industry median of 0.90. Aimei Health Technology Co's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Aimei Health Technology Co (AFJK), the current Equity-to-Asset is 0.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AFJK has been successfully added to your 
